HROC103 T0 M1 Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | This is one of a series of cell lines which have been established by PD Dr. Michael Linnebacher from a PDTx (Patient-derived Tumor xenograft) since 2006. |
|---|---|
| 生物體 | Human |
| 組織 | Colorectal, Established from a PDx (patient-derived xenograft) of primary CRC tissue (Colon ascendens, TNM stage T2N1M0R0L0V0, grade G2, Lk(n) + 2, ∑ Lk(n) 23). |
| 疾病 | Adenocarcinoma |
| 轉移部位 | Regional lymph node involvement (TNM N1; Lk(n)+2 of 23 examined); no distant metastasis (M0) |
| 應用 | Colorectal cancer research; CRC biology; PDx-derived cell line research; drug sensitivity and targeted therapy evaluation; p53/KRAS mutant CRC modeling; MSS CRC immunology; patient-matched HROC biobank studies |
| 同義詞 | HROC103 |
特徵
| 年齡 | 44 years |
|---|---|
| 性別 | Male |
| 族裔 | Caucasian |
| 形態學 | Small cells in colonies |
| 細胞類型 | Epithelial |
| 生長特性 | Adherent |
監管數據
| 引用 | HROC103 T0 M1 (Cytion catalog number 300802) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_1D10 |
| 轉基因狀態 | No genetic modification; wildtype patient-derived CRC cell line established from a patient-derived xenograft by PD Dr. Linnebacher |
生物分子資料
| 倍性狀態 | Aneuploid |
|---|---|
| MSI 狀態 | MSS |
| 突變譜 | P53 mut, APC mut, K-RasG12VA, N-Raswt, H-Raswt, PIK3CAwt, B-Rafwt |
處理方式
| 培養基 | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 倍增時間 | 30 hours |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 拆股比例 | 1 to 3 |
| 播種密度 | 2 x 104 cells/cm2 |
| 流體更新 | Every 3 to 5 days |
| 解凍後的恢復 | Few days |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|